Compugen | CGEN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Arca Biopharma USD 46.93M 44.32M 2025-12
aTyr Pharma USD 6.15M 11.07M 2025-09
Bio Path 13.65M 3.37M 2022-09
Brainstorm Cell Therapeutics USD 5K 819K 2025-09
Cara Therapeutics USD 21.42M 770K 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
Immunic USD 15.48M 19.65M 2025-12
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
RedHill Biopharma USD 2.87M 1.75M 2025-06
TherapeuticsMD 523K 89K 2024-06